Starling Oncology, Inc. Stock Analysis & AI Score
Starling Oncology, Inc. (STLN) has an ST Score of 53.9 (B-), driven by its Momentum (A-) and held back by its Profitability (D+). Analysts rate it Buy.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Care Facilities |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Starling Oncology, Inc. (STLN) has an ST Score of 53.9 (B-), driven by its Momentum (A-) and held back by its Profitability (D+). Analysts rate it Buy.
- Strongest
- MomentumA-
- Weakest
- ProfitabilityD+
All factor grades
- MomentumA-
- ValuationB
- GrowthB
- Financial StrengthC
- ProfitabilityD+
Contact
STLN stock: frequently asked questions
What is STLN's ST Score?
Starling Oncology, Inc. (STLN) has an ST Score of 53.9 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is STLN a buy, hold, or sell?
Analysts rate STLN a Buy. Our ST Score grades it B- (53.9/100). The ST Score is a data-driven signal, not a recommendation.
What are STLN's factor grades?
Valuation B, Profitability D+, Financial Strength C, Momentum A-, Growth B.
What is STLN's valuation grade?
Starling Oncology, Inc. (STLN) earns a valuation grade of B, measured against Medical - Care Facilities peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is STLN's growth grade?
Starling Oncology, Inc. (STLN) earns a growth grade of B, measured against Medical - Care Facilities peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is STLN's profitability grade?
Starling Oncology, Inc. (STLN) earns a profitability grade of D+, measured against Medical - Care Facilities peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is STLN's financial strength grade?
Starling Oncology, Inc. (STLN) earns a financial strength grade of C, measured against Medical - Care Facilities peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.